3-苯基-2-丙烯-1-醇； 反式-肉桂醇

索拉非尼;4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺;对甲苯磺酸索拉非尼;索拉菲尼;索+E51拉尼;索拉非尼碱;索拉替尼;索拉菲尼碱;O-(2-氨乙基)-O`-[2-(BOC-氨乙基]五缩六乙二醇;Sorafenib tosylate 索拉非尼;Sorafenib tosylate 索拉非尼 标准品;甲磺酸索拉非尼;硫酸颠茄碱;索拉非尼、索拉非尼碱、索拉菲尼;索拉非尼-D4;索拉非尼标准品;索拉非尼对甲苯磺酸索拉非尼;索拉非尼杂质;索拉非尼杂质 库存;索拉非尼杂质及标准品;索拉非尼中间体;索拉菲尼标准品及杂质;索拉菲尼杂质;索拉菲尼杂质及标准品;索拉菲尼中间体2;托西酸索拉非尼;Raf抑制剂;舒拉非尼;索拉菲尼单体;索拉替尼 

3-Phenyl-2-propen-1-ol

Sorafenib tosylate;sorafenib;SORAFENIB-D3;SORAFENIB TOLSYLATE;RAF1 KINASE INHIBITOR II;N-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)-((4-(2-(N-METHYL-CARBAMOYL)(4-PYRIDYLOXY))PHENYL)AMINO)CARBOXAMIDE;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide;BAY 43-9006;SORAFENIB MESYLATE;BAY-43-9006;Sorafenib (BAY 43-9006);Sorafenib base;Sorafenib Free Base;Epirubicin HCl; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide;BAY-43-900;Forafenib;Nexavar;4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide;N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy;4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide;4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy

4407-36-7

C₉H₁₀O

134.20